Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
58.50
-2.45 (-4.02%)
Sep 10, 2026, 11:57 AM HKT

HKG:2315 Statistics

Total Valuation

HKG:2315 has a market cap or net worth of HKD 56.25 billion. The enterprise value is 55.84 billion.

Market Cap56.25B
Enterprise Value 55.84B

Important Dates

The last earnings date was Thursday, August 27, 2026.

Earnings Date Aug 27, 2026
Ex-Dividend Date n/a

Share Statistics

HKG:2315 has 446.90 million shares outstanding. The number of shares has increased by 1.95% in one year.

Current Share Class 110.78M
Shares Outstanding 446.90M
Shares Change (YoY) +1.95%
Shares Change (QoQ) -3.90%
Owned by Insiders (%) 14.07%
Owned by Institutions (%) 24.36%
Float 155.45M

Valuation Ratios

The trailing PE ratio is 61.46 and the forward PE ratio is 60.65.

PE Ratio 61.46
Forward PE 60.65
PS Ratio 28.67
PB Ratio 20.08
P/TBV Ratio 20.21
P/FCF Ratio 321.30
P/OCF Ratio 113.74
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 88.84, with an EV/FCF ratio of 318.96.

EV / Earnings 132.04
EV / Sales 28.46
EV / EBITDA 88.84
EV / EBIT 116.49
EV / FCF 318.96

Financial Position

The company has a current ratio of 3.42, with a Debt / Equity ratio of 0.29.

Current Ratio 3.42
Quick Ratio 2.79
Debt / Equity 0.29
Debt / EBITDA 1.25
Debt / FCF 4.57
Interest Coverage 5.96

Financial Efficiency

Return on equity (ROE) is 22.05% and return on invested capital (ROIC) is 20.01%.

Return on Equity (ROE) 22.05%
Return on Assets (ROA) 8.64%
Return on Invested Capital (ROIC) 20.01%
Return on Capital Employed (ROCE) 13.48%
Weighted Average Cost of Capital (WACC) 5.11%
Revenue Per Employee 1.02M
Profits Per Employee 220,020
Employee Count1,922
Asset Turnover 0.55
Inventory Turnover 35.74

Taxes

In the past 12 months, HKG:2315 has paid 12.34 million in taxes.

Income Tax 12.34M
Effective Tax Rate 2.83%

Stock Price Statistics

The stock price has increased by +135.88% in the last 52 weeks. The beta is 0.14, so HKG:2315's price volatility has been lower than the market average.

Beta (5Y) 0.14
52-Week Price Change +135.88%
50-Day Moving Average 57.08
200-Day Moving Average 48.22
Relative Strength Index (RSI) 51.42
Average Volume (20 Days) 2,007,936

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:2315 had revenue of HKD 1.96 billion and earned 422.88 million in profits. Earnings per share was 0.99.

Revenue1.96B
Gross Profit 1.54B
Operating Income 489.33M
Pretax Income 435.21M
Net Income 422.88M
EBITDA 606.14M
EBIT 489.33M
Earnings Per Share (EPS) 0.99
Full Income Statement

Balance Sheet

The company has 1.22 billion in cash and 800.62 million in debt, with a net cash position of 415.08 million or 0.93 per share.

Cash & Cash Equivalents 1.22B
Total Debt 800.62M
Net Cash 415.08M
Net Cash Per Share 0.93
Equity (Book Value) 2.80B
Book Value Per Share 6.26
Working Capital 1.39B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 494.55 million and capital expenditures -319.49 million, giving a free cash flow of 175.06 million.

Operating Cash Flow 494.55M
Capital Expenditures -319.49M
Depreciation & Amortization 118.27M
Net Borrowing -296.12M
Free Cash Flow 175.06M
FCF Per Share 0.39
Full Cash Flow Statement

Margins

Gross margin is 78.60%, with operating and profit margins of 24.94% and 21.56%.

Gross Margin 78.60%
Operating Margin 24.94%
Pretax Margin 22.19%
Profit Margin 21.56%
EBITDA Margin 30.90%
EBIT Margin 24.94%
FCF Margin 8.81%

Dividends & Yields

HKG:2315 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 4.11%
Buyback Yield -1.95%
Shareholder Yield -1.95%
Earnings Yield 0.75%
FCF Yield 0.31%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

HKG:2315 has an Altman Z-Score of 11.48 and a Piotroski F-Score of 8.

Altman Z-Score 11.48
Piotroski F-Score 8